ANIKA THERAPEUTICS INC (ANIK:NASDAQ)
$14.9 0.09 (0.6077%)
Analysed ANIKA THERAPEUTICS INC (ANIK:NASDAQ) News Sources
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
07-04-2026
yahoo.com
Telix Strengthens Board with Additional Director Appointments
08-04-2026
yahoo.com
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
15-04-2026
yahoo.com
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
16-04-2026
yahoo.com
Anika Reports First Quarter 2026 Financial Results
29-04-2026
yahoo.com
Anika Therapeutics Q1 Earnings Call Highlights
29-04-2026
marketbeat.com
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary
29-04-2026
moby.co
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
30-04-2026
yahoo.com
President of Anika Therapeutics Picks Up 51% More Stock
03-05-2026
yahoo.com
What is the current price of ANIKA THERAPEUTICS INC (ANIK:NASDAQ)?
The current price of ANIKA THERAPEUTICS INC (ANIK:NASDAQ) is $14.9.
ANIKA THERAPEUTICS INC (ANIK:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANIKA THERAPEUTICS INC (ANIK:NASDAQ) since the previous trading day is $0.09.
ANIKA THERAPEUTICS INC (ANIK:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANIKA THERAPEUTICS INC (ANIK:NASDAQ) since the previous trading day is 0.6077%.
What is the most recent average sentiment score for ANIKA THERAPEUTICS INC (ANIK:NASDAQ)?
The most recent average sentiment score for ANIKA THERAPEUTICS INC (ANIK:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for ANIKA THERAPEUTICS INC (ANIK:NASDAQ)?
The most recent sentiment for ANIKA THERAPEUTICS INC (ANIK:NASDAQ) is .
SEC-8K** Filing Available For ANIKA THERAPEUTICS INC (ANIK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.